Clinical Trials Insight: 700026913
Latest Information Update: 13 Sep 2007
At a glance
- Drugs NGX 267 (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors TorreyPines Therapeutics Inc
- 13 Sep 2007 New trial record.
Latest Information Update: 13 Sep 2007